comparemela.com
Home
Live Updates
FDA Grants Fast Track Designation to PT886 for the Treatment
FDA Grants Fast Track Designation to PT886 for the Treatment
FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer
PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.
Related Keywords
United States ,
Ming Wang ,
Phanes Therapeutics Inc ,
Phanes Therapeutics ,
Patients With ,
Advanced Gastric ,
Gastroesophageal Junction ,
Fast Track ,
Therapeutics Announces First Patient Dosed ,
Announces Clinical Trial Collaboration ,
Supply Agreement ,